본문 바로가기
KERD
논문KCI 등재

임파선내항원특이면역요법

Intralymphatic allergen-specific immunotherapy

이상민|정주현|강성윤|이상표
대한 소아알레르기 호흡기학회 (The Korean Academy Of Pediatric Allergy And Respiratory Disease)|2020.04|Allergy Asthma & Respiratory Disease (알레르기 천식 호흡기질환)|제8권 제2호|pp. 53-65|DOI https://doi.org/10.4168/aard.2020.8.2.53

2

조회

0

다운로드

3

인용

0

참고문헌

키워드

AllergenInjectionsImmunotherapyIntralymphatic
주제분류소아과학

초록

Although allergen-specific immunotherapy (AIT) is a standard treatment for allergic diseases, only 5% or less of patients in whom AIT is indicated have been receiving immunotherapy because AIT needs a long-term therapeutic duration of up to 5 years. To overcome this limitation of conventional AIT, Kündig and his colleagues first introduced intralymphatic immunotherapy (ILIT) in patients with allergic rhinitis, publishing their results in 2008. Since then, 10 clinical trials that evaluated therapeutic efficacies and adverse effects of ILIT have been conducted. This article reviews the clinical trials of ILIT and suggests unmet needs in research fields of ILIT.

Abstract

Although allergen-specific immunotherapy (AIT) is a standard treatment for allergic diseases, only 5% or less of patients in whom AIT is indicated have been receiving immunotherapy because AIT needs a long-term therapeutic duration of up to 5 years. To overcome this limitation of conventional AIT, Kündig and his colleagues first introduced intralymphatic immunotherapy (ILIT) in patients with allergic rhinitis, publishing their results in 2008. Since then, 10 clinical trials that evaluated therapeutic efficacies and adverse effects of ILIT have been conducted. This article reviews the clinical trials of ILIT and suggests unmet needs in research fields of ILIT.

참고문헌 (29)

  1. Noon L, "Prophylactic inoculation against hay fever. Historical document", Ann Allergy, 18, pp.287~291 (1960)
  2. Kim ST, "Allergen-specific intralymphatic immunotherapy in human and animal studies", Asia Pac Allergy, 7, pp.131~137 (2017)
  3. Gaugris S, "Burden of concomitant allergic rhinitis in adults with asthma", J Asthma, 43, pp.1~7 (2006)
  4. Ozdoganoglu T, "The burden of allergic rhinitis and asthma", Ther Adv Respir Dis, 6, pp.11~23 (2012)
  5. 유광하, "Burden of Respiratory Disease in Korea: An Observational Study on Allergic Rhinitis, Asthma, COPD, and Rhinosinusitis", Allergy, Asthma & Immunology Research, 8(6), pp.527~534 (2016), 대한천식알레르기학회
  6. Kündig TM, "Fibroblasts as efficient antigen-presenting cells in lymphoid organs", Science, 268, pp.1343~1347 (1995)
  7. Zinkernagel RM, "Antigen localisation regulates immune responses in a dose-and time-dependent fashion : a geographical view of immune reactivity", Immunol Rev, 156, pp.199~209 (1997)
  8. Zinkernagel RM, "Localization dose and time of antigens determine immune reactivity", Semin Immunol, 12, pp.163~171 (2000)
  9. Senti G, "Intralymphatic immunotherapy", Curr Opin Allergy Clin Immunol, 9, pp.537~543 (2009)
  10. Senti G, "Intralymphatic immunotherapy : from the rationale to human applications", Curr Top Microbiol Immunol, 352, pp.71~84 (2011)
  11. Senti G, "Intralymphatic immunotherapy", World Allergy Organ J, 8, pp.9~ (2015)
  12. Senti G, "Novel delivery routes for allergy immunotherapy : intralymphatic, epicutaneous, and intradermal", Immunol Allergy Clin North Am, 36, pp.25~37 (2016)
  13. von Moos S, "Novel administration routes for allergen-specific immunotherapy : a review of intralymphatic and epicutaneous allergen-specific immunotherapy", Immunol Allergy Clin North Am, 31, pp.391~406 (2011)
  14. Senti G, "Intralymphatic allergen administration renders specific immunotherapy faster and safer : a randomized controlled trial", Proc Natl Acad Sci U S A, 105, pp.17908~17912 (2008)
  15. Senti G, "Intralymphatic immunotherapy for cat allergy induces tolerance after only 3 injections", J Allergy Clin Immunol, 129, pp.1290~1296 (2012)
  16. Hylander T, "Intralymphatic allergen-specific immunotherapy : an effective and safe alternative treatment route for pollen-induced allergic rhinitis", J Allergy Clin Immunol, 131, pp.412~420 (2013)
  17. Hylander T, "Intralymphatic immunotherapy of pollen-induced rhinoconjunctivitis : a double-blind placebo-controlled trial", Respir Res, 17, pp.10~ (2016)
  18. Hellkvist L, "Intralymphatic immunotherapy with 2 concomitant allergens, birch and grass : a randomized, double-blind, placebo-controlled trial", J Allergy Clin Immunol, 142, pp.1338~1341 (2018)
  19. Ahlbeck L, "Intralymphatic allergen immunotherapy against pollen allergy : a 3-year open follow-up study of 10 patients", Ann Allergy Asthma Immunol, 121, pp.626~627 (2018)
  20. Witten M, "Is intralymphatic immunotherapy ready for clinical use in patients with grass pollen allergy", J Allergy Clin Immunol, 132, pp.1248~1252 (2013)
  21. Schmid JM, "Intralymphatic immunotherapy induces allergen specific plasmablasts and increases tolerance to skin prick testing in a pilot study", Clin Transl Allergy, 6, pp.19~ (2016)
  22. Patterson AM, "Three-injection intralymphatic immunotherapy in adolescents and young adults with grass pollen rhinoconjunctivitis", Ann Allergy Asthma Immunol, 116, pp.168~170 (2016)
  23. 이상표, "A Pilot Study of Intralymphatic Immunotherapy for House Dust Mite, Cat, and Dog Allergies", Allergy, Asthma & Immunology Research, 9(3), pp.272~277 (2017), 대한천식알레르기학회
  24. 이상표, "Intralymphatic Immunotherapy Alleviates Allergic Symptoms During Allergen Exposure in Daily Life", Allergy, Asthma & Immunology Research, 10(2), pp.180~181 (2018), 대한천식알레르기학회
  25. Gödicke V, "Registration trials for specific immunotherapy in Europe : advanced guidance from the new European Medical Agency guideline", Allergy, 65, pp.1499~1505 (2010)
  26. Canonica GW, "Recommendations for standardization of clinical trials with Allergen Specific Immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforce", Allergy, 62, pp.317~324 (2007)
  27. Kündig TM, "Intralymphatic immunotherapy : time interval between injections is essential", J Allergy Clin Immunol, 133, pp.930~931 (2014)
  28. Freiberger SN, "IgG4 but no IgG1 antibody production after intralymphatic immunotherapy with recombinant MAT-Feld1 in human", Allergy, 71, pp.1366~1370 (2016)
  29. Senti G, "Intralymphatic immunotherapy : update and unmet needs", Int Arch Allergy Immunol, 178, pp.141~149 (2019)

관련 논문AI추천

Recent Advances in Allergen-Specific Immunotherapy in Humans: A Systematic Review강성윤, 김태범, 이상민, 이상표, Shin Yoo Seob대한면역학회 · Immune Network2022 · 제22권 제1호대한천식알레르기학회 설하면역요법 진료지침강성윤, 고영일, 김경훈, 김선태, 김주희, 남동호, 류광희, 민진영, 박경희, 박소영, 박중원, 성명순, 신유섭, 심정연, 안영민, 양은애, 이상민, 이영수, 이용원, 이화영, 정은희, 지혜미, 최선희, 최정희, 하은교, 한두희, 한만용, 대한천식알레르기학회 면역요법/알레르겐연구팀대한 소아알레르기 호흡기학회 · Allergy Asthma & Respiratory Disease2024 · 제12권 제3호알레르기비염의 치료에 있어서의 설하면역요법의 역할김성완, 정수영대한 소아알레르기 호흡기학회 · Allergy Asthma & Respiratory Disease2014 · 제2권 제2호알레르기성 호흡기 질환에서의 항원특이면역요법강성윤, 양민석, 이상민, 이상표대한내과학회 · 대한내과학회지2020 · 제95권 제6호통년성 알레르기 비염에서 피하 및 설하 면역 요법의 일대일 비교: 체계적인 고찰 및 메타 분석김효빈, 박도양, 심진아, 정수지, 최정희대한 소아알레르기 호흡기학회 · Allergy Asthma & Respiratory Disease2024 · 제12권 제1호알레르기비염에서 알레르겐 특이 면역요법박중원대한내과학회 · 대한내과학회지2013 · 제84권 제6호

이 간행물의 다른 논문 (8건)

진료 현장에서 소아 마이코플라스마 폐렴을 어떻게 치료할 것인가?양현종pp. 51-52입원한 소아의 마이코플라스마 폐렴에서 치료 행태 분석: 다기관 후향적 연구정혜리, 장광천, 황윤하, 이영주, 안영민, 심정연, 정은희pp. 66-72일반병동에 입원한 호흡부전 소아에서 고습도 고유량 비캐뉼라의 유용성이미희, 정은희, 조은영, 송근백, 길홍량pp. 73-79전연령 중증도별 식품알레르기의 주요 원인: 단일기관 최근 10년 후향적 조사 연구예영민, 최현나, 이은주, 남동호, 박해심, 신유섭, 정경욱, 윤지원, 이수영pp. 80-88Glutathione 주사에 의해 유발된 치명적인 천식발작 1예김태희, 박혜정, 강민석, 김형중, 김재경, 박정환, 권도선, 변민광, 조재화pp. 89-91
원문 보기